+7 (701) 759 90 19
USD 420.32 EUR 509.34
RUB 5.7 CNY 64.85
News

Germany 'optimistic’ over vaccine; Oxford-AstraZeneca results ‘fantastic’

24 November 2020 09:50
Share in:
Germany 'optimistic’ over vaccine; Oxford-AstraZeneca results ‘fantastic’

BERLIN/LONDON. KAZINFORM Germany has sealed an agreement to purchase at least 5 million doses of a potential Covid-19 vaccine developed by IDT Biologika which is in the first phase of clinical trials, while a vaccine being produced by Oxford University in England and AstraZeneca is 90 percent effective, studies have shown.

Related news
Dubai-Almaty passenger tests positive for COVID-19 54 lost their lives to COVID-19 in Kazakhstan in past week 307 COVID-19 patients in critical condition in Kazakhstan

At a press conference after visiting the pharmaceutical company’s facilities on Monday, health minister Jens Spahn said that vaccines were «the key to getting out of the pandemic» and spoke of his «pride» that three German firms - BioNTech, Curevac and IDT - were at the forefront of «promising» vaccine developments.

«The crisis shows the best in us,» Spahn said, according to a statement on the federal government’s website, EFE-EPA reports.



Share in:
+7
Send
Employees online
Editor
Nurmaganbetova Zhanna
Nurmaganbetova Zhanna
954-048
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048

Archive